A further study, using exenatide (via subcutaneous infusion) in a transgenic mouse model of MSA, showed positive effects on insulin resistance and monomeric alpha‐synuclein levels in the striatum, as well as improving survival of nigral dopamine neurons.9 This evidence concerns the gene SNCA and multiple system atrophy.